Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure

Molecular and Cellular Neuroscience

Volumn 31, Issue 1, 2006, Pages 15-25

  Wang, Xun ^a   Gu, Zhenglin ^a   Zhong, Ping ^a   Chen, Guojun ^a   Feng, Jian ^a   Yan, Zhen ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN BINDING PROTEIN; CLOZAPINE; DOPAMINE 4 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PROTEIN CAMK2; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ELECTROPHYSIOLOGY; MALE; MODELS, ANIMAL; PATCH-CLAMP TECHNIQUES; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D4; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 30044450166     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.08.018     Document Type: Article

References (68)

1. B. Adams, and B. Moghaddam Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine J. Neurosci. 18 1998 5545 5554
2. M. Akil, J.N. Pierri, R.E. Whitehead, C.L. Edgar, C. Mohila, A.R. Sampson, and D.A. Lewis Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects Am. J. Psychiatry 156 1999 1580 1589
3. R.M. Allen, and S.J. Young Phencyclidine-induced psychosis Am. J. Psychiatry 135 1978 1081 1084
4. N.C. Andreasen, D.S. O'Leary, M. Flaum, P. Nopoulos, G.L. Watkins, L.L. Boles Ponto, and R.D. Hichwa Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients Lancet 349 1997 1730 1734
5. V.P. Bakshi, N.R. Swerdlow, and M.A. Geyer Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response J. Pharmacol. Exp. Ther. 271 1994 787 794
6. A. Carlsson Antipsychotic drugs and catecholamine synapses J. Psychiatr. Res. 11 1974 57 64
7. A. Carlsson The current status of the dopamine hypothesis of schizophrenia Neuropsychopharmacology 1 1988 179 186
8. C. Chen, D.G. Rainnie, R.W. Greene, and S. Tonegawa Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II Science 266 1994 291 294
9. G. Chen, P. Greengard, and Z. Yan Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex Proc. Natl. Acad. Sci. U. S. A. 101 2004 2596 2600
10. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
11. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 1976 481 483
12. K.L. Davis, R.S. Kahn, G. Ko, and M. Davidson Dopamine in schizophrenia: a review and reconceptualization Am. J. Psychiatry 148 1991 1474 1486
13. B. Dean, K. Opeskin, G. Pavey, C. Hill, and N. Keks Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia J. Neural Transm. 104 1997 1371 1381
14. A.Y. Deutch The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia J. Neural Transm., Suppl. 36 1992 61 89
15. A.Y. Deutch, S.Y. Tam, A.S. Freeman, M.B. Bowers Jr., and R.H. Roth Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response Eur. J. Pharmacol. 134 1987 257 264
16. S.C. Dulawa, D.K. Grandy, M.J. Low, M.P. Paulus, and M.A. Geyer Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli J. Neurosci. 19 1999 9550 9556
17. J. Feng, X. Cai, J.H. Zhao, and Z. Yan Serotonin receptors modulate GABAA receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons J. Neurosci. 21 2001 6502 6511
18. A.S. Freeman, and B.S. Bunney The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity Eur. J. Pharmacol. 104 1984 287 293
19. S.A. Glase, H.C. Akunne, L.M. Georgic, T.G. Heffner, R.G. MacKenzie, P.J. Manley, T.A. Pugsley, and L.D. Wise Substituted [(4-phenylpiperazinyl)-methyl] benzamides: selective dopamine D4 agonists J. Med. Chem. 40 1997 1771 1772
20. P.S. Goldman-Rakic Working memory dysfunction in schizophrenia J. Neuropsychiatry Clin. Neurosci. 6 1994 348 357
21. A.A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia Neuroscience 41 1991 1 24
22. Z. Gu, P. Zhong, and Z. Yan Activation of muscarinic receptors inhibits β-amyloid peptide-induced signaling in cortical slices J. Biol. Chem. 278 2003 17546 17556
23. G.E. Handelmann, P.C. Contreras, and T.L. O'Donohue Selective memory impairment by phencyclidine in rats Eur. J. Pharmacol. 140 1987 69 73
24. S. Hestrin, R.A. Nicoll, D.J. Perkel, and P. Sah Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices J. Physiol. 422 1990 203 225
25. B. Hille Modulation of ion-channel function by G-protein-coupled receptors Trends Neurosci. 17 1994 531 536
26. H. Hondo, Y. Yonezawa, T. Nakahara, K. Nakamura, M. Hirano, H. Uchimura, and N. Tashiro Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study Brain Res. 633 1994 337 342
27. T. Itil, A. Keskiner, N. Kiremitci, and J.M.C. Holden Effect of phencyclidine in chronic schizophrenics Can. J. Psychiatry 12 1967 209 212
28. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
29. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 1999 201 225
30. J.D. Jentsch, J.D. Elsworth, D.E. Redmond Jr., and R.H. Roth Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966 J. Neurosci. 17 1997 1769 1775
31. J.D. Jentsch, A. Tran, D. Le, K.D. Youngren, and R.H. Roth Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat Neuropsychopharmacology 17 1997 92 99
32. J.D. Jentsch, A. Tran, J.R. Taylor, and R.H. Roth Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence Psychopharmacology (Berlin) 138 1998 89 95
33. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers Jr., and D.S. Charney Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch. Gen. Psychiatry 51 1994 199 214
34. A.C. Lahti, B. Koffel, D. LaPorte, and C.A. Tamminga Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1995 9 19
35. D.A. Lewis, and J.A. Lieberman Catching up on schizophrenia: natural history and neurobiology Neuron 28 2000 325 334
36. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, and R. Kelly Study of a new schizophrenic-like drug: sernyl Arch. Neurol. Psychiatry 81 1959 363 369
37. A.K. Malhotra, C.M. Adler, S.D. Kennison, I. Elman, D. Pickar, and A. Breier Clozapine blunts N-methyl-d-aspartate antagonist-induced psychosis: a study with ketamine Biol. Psychiatry 42 1997 664 668
38. J.H. Meador-Woodruff, V. Haroutunian, P. Powchik, M. Davidson, K.L. Davis, and S.J. Watson Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia Arch. Gen. Psychiatry 54 1997 1089 1095
39. S.G. Miller, and M.B. Kennedy Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch Cell 44 1986 861 870
40. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
41. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J. Neurosci. 17 1997 2921 2927
42. A.R. Mohn, R.R. Gainetdinov, M.G. Caron, and B.H. Koller Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 98 1999 427 436
43. L. Mrzljak, C. Bergson, M. Pappy, R. Huff, R. Levenson, and P.S. Goldman-Rakic Localization of dopamine D4 receptors in GABAergic neurons of the primate brain Nature 381 1996 245 248
44. G. Novak, P. Seeman, and T. Tallerico Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex Brain Res. Mol. Brain Res. 82 2000 95 100
45. J.N. Oak, J. Oldenhof, and H.H. Van Tol The dopamine D(4) receptor: one decade of research Eur. J. Pharmacol. 405 2000 303 327
46. J.W. Olney, J.W. Newcomer, and N.B. Farber NMDA receptor hypofunction model of schizophrenia J. Psychiatr. Res. 33 1999 523 533
47. S.N. Raja, and P.G. Guyenet Effects of phencyclidine on the spontaneous activity of monoaminergic neurons Eur. J. Pharmacol. 63 1980 229 233
48. D.A. Roberts, D. Balderson, S.M. Pickering-Brown, J.F. Deakin, and F. Owen The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls Schizophr. Res. 20 1996 171 174
49. M. Rubinstein, T.J. Phillips, J.R. Bunzow, T.L. Falzone, G. Dziewczapolski, G. Zhang, Y. Fang, J.L. Larson, J.A. McDougall, J.A. Chester, C. Saez, T.A. Pugsley, O. Gershanik, M.J. Low, and D.K. Grandy Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine Cell 90 1997 991 1001
50. M. Rubinstein, C. Cepeda, R.S. Hurst, J. Flores-Hernandez, M.A. Ariano, T.L. Falzone, L.B. Kozell, C.K. Meshul, J.R. Bunzow, M.J. Low, M.S. Levine, and D.K. Grandy Dopamine D4 receptor-deficient mice display cortical hyperexcitability J. Neurosci. 21 2001 3756 3763
51. A. Sawa, and S.H. Snyder Schizophrenia: diverse approaches to a complex disease Science 296 2002 692 695
52. P. Seeman, T. Lee, M. Chau-Wong, and K. Wong Antipsychotic drug doses and neuroleptic/dopamine receptors Nature 261 1976 717 719
53. P. Seeman, H.C. Guan, and H.H. Van Tol Dopamine D4 receptors elevated in schizophrenia Nature 365 1993 441 445
54. S.H. Snyder Phencyclidine Nature 285 1980 355 356
55. N.C. Stefanis, J.N. Bresnick, R.W. Kerwin, W.N. Schofield, and G. McAllister Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain Brain Res. Mol. Brain Res. 53 1998 112 119
56. R.E. Steinpreis, J.D. Sokolowski, A. Papanikolaou, and J.D. Salamone The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat Pharmacol. Biochem. Behav. 47 1994 579 585
57. C.A. Tamminga Schizophrenia and glutamatergic transmission Crit. Rev. Neurobiol. 12 1998 21 36
58. D. Tardito, G.B. Tura, L. Bocchio, S. Bignotti, R. Pioli, G. Racagni, and J. Perez Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients Neuropsychopharmacology 23 2000 216 219
59. H.H. Van Tol, J.R. Bunzow, H.C. Guan, R.K. Sunahara, P. Seeman, H.B. Niznik, and O. Civelli Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine Nature 350 1991 610 614
60. A. Verma, and B. Moghaddam NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine J. Neurosci. 16 1996 373 379
61. 4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex J. Neurosci. 22 2002 9185 9193
62. 4 signaling in prefrontal cortex J. Neurosci. 23 2003 9852 9861
63. K. Wedzony, A. Chocyk, M. Mackowiak, K. Fijal, and A. Czyrak Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study J. Physiol. Pharmacol. 51 2000 205 221
64. D. Weinberger, K. Berman, and R. Zec Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence Arch. Gen. Psychiatry 43 1986 114 124
65. J.M. Wilson, S. Sanyal, and H.H.M. Van Tol Dopamine D-2 and D-4 receptor ligands: relation to antipsychotic action Eur. J. Pharmacol. 351 1998 273 286
66. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein kinase C-insensitive pathway J. Neurophysiol. 77 1997 1003 1015
67. E.Y. Yuen, Q. Jiang, P. Chen, Z. Gu, J. Feng, and Z. Yan Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism J. Neurosci. 25 2005 5488 5501
68. P. Zhong, Z. Gu, X. Wang, H. Jiang, J. Feng, and Z. Yan Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease J. Biol. Chem. 278 2003 26888 26896